He Xiaomei, Zhao Lina, Guo Xuejia, Zhang Ning, Sun Yuna, Wang Jun, Wang Zhen, Liu Gaiqin
Department of Ultrasound Echocardiography, First Hospital of Hebei Medical University, Shijiazhuang 050031, China
Department of Cardiology, Shenzhen Hospital, University of Hong Kong, Shenzhen 518053, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Jun 28;42(6):629-634. doi: 10.11817/j.issn.1672-7347.2017.06.005.
To evaluate the safety of cardiac catheterization intervention therapy and transthoracic small incision surgery in the occlusion bydomestic occluder under echocardiography guiding in patients with atrial septal defect (ASD). Methods: A total of 1 080 patients with ASD in the occlusion by domestic occluder were analyzed retrospectively, and the interventional treatment were performed in 734 cases through cardiac catheterization intervention therapy and 346 cases through transthoracic small incision surgery. The patients undergone cardiac catheterization intervention therapy were guided under the digital substraction angiography (DSA) and were monitored by transthoracic echocardiography (TTE) in the whole interventional process, and the efficacy was evaluated with TTE. The occlusion of transthoracic small incision surgery was guided under the transesophageal echocardiography (TEE), which was used to monitor the position of occluder and evaluate the efficacy immediately. Results: Two kinds of intervention in the occlusion by domestic occluder had achieved satisfactory results in patients with ASD. There was no statistically difference in the longest size of ASD between the 2 intervention methods, while there were statistically differences in the ratio between ASD longest diameter and atrial septal length, and the size of the occlusion, and the disparity between the size of the occluder and ASD longest diameter (D value), respectively (all P<0.05). When the size of arithmetic mean of the ASD was <30 mm, the success rate of the 2 methods was both 100%. When the size of arithmetic mean of the ASD was ≥30 mm, the success rate was 100% in the transthoracic small incision surgery and 50% in the cardiac catheterization intervention therapy. Conclusion: Domestic occluder is safe. Compared with the imported one, its cost is lower. When the size of the defects is same, the occlusion is smaller in the transthoracic small incision surgery compared with that in the cardiac catheterization intervention therapy. When the size of arithmetic mean of the ASD is ≥30 mm, the success rate of the transthoracic small incision surgery is higher compared with the cardiac catheterization intervention therapy. When the cardiac catheterization intervention therapy fails, the transthoracic small incision surgery may be a better choice.
评估国产封堵器在超声心动图引导下经心导管介入治疗和经胸小切口手术封堵房间隔缺损(ASD)患者的安全性。方法:回顾性分析1080例应用国产封堵器封堵ASD的患者,其中734例经心导管介入治疗,346例经胸小切口手术。心导管介入治疗患者在数字减影血管造影(DSA)引导下进行,整个介入过程采用经胸超声心动图(TTE)监测,并用TTE评估疗效。经胸小切口手术封堵在经食管超声心动图(TEE)引导下进行,用于监测封堵器位置并立即评估疗效。结果:两种国产封堵器介入治疗ASD患者均取得满意效果。两种介入方法的ASD最大径差异无统计学意义,但ASD最大径与房间隔长度之比、封堵尺寸、封堵器尺寸与ASD最大径差值(D值)差异有统计学意义(均P<0.05)。当ASD算术平均径<30 mm时,两种方法成功率均为100%。当ASD算术平均径≥30 mm时,经胸小切口手术成功率为100%,心导管介入治疗成功率为50%。结论:国产封堵器安全,与进口封堵器相比成本较低。在缺损大小相同的情况下,经胸小切口手术封堵尺寸小于心导管介入治疗。当ASD算术平均径≥30 mm时,经胸小切口手术成功率高于心导管介入治疗。当心导管介入治疗失败时,经胸小切口手术可能是更好的选择。